Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Adds University of Colorado to CombiCore Program

This article has been updated to correct the headline, which originally named CU Boulder as the partner institute.


NEW YORK, Jan. 6 (GenomeWeb News) - The University of Colorado Health Sciences Center will buy CombiMatrix's microarray products under the CombiCore access program, Acacia Research, CombiMatrix's parent company, said today.


Under the non-exclusive agreement, researchers can purchase CustomArrays and CatalogArrays, including array-processing services performed at the university's Microarray Core Facility.


The company markets, sells and delivers products to universities under the CombiCore program.


Financial details were not disclosed.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.